News Tarek Samad takes on task of delivering on Lundbeck's R&D Lundbeck names Tarek Samad to replace its retiring R&D chief, Johan Luthman, and he is facing a tough task as the firm heads towards a patent cliff.
News Sanofi names ex-Roche exec Fontoura as R&D chief Paulo Fontoura, currently chief medical officer of Xaira Therapeutics, will replace Houmab Ashrafian as Sanofi's R&D head on 1st September.
News Pushy NHS chatbots 'can put patients off screening' Amid the push to digitise the UK health service, a study has sounded a note of caution about entrusting important patient appointments to chatbots.
News Jen Norton appointed market access leader at EVERSANA EVERSANA has named Jen Norton as president of its recently formed Market Access & Value division.
R&D Changing Faces: Boards of Directors and Advisory Boards – Ap... Boardrooms and advisory panels across biotech, pharma, digital health, and life sciences suppliers saw a wave of high‑profile additions in April.
Digital Changing Faces: Digital and supplier hires – April 2026 Leadership changes across digital health, diagnostics, clinical trial technology, and life sciences suppliers continued in April.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.